TrialOral oncology2016

Comparisons of dysphagia and quality of life (QOL) in comparable patients with HPV-positive oropharyngeal cancer receiving chemo-irradiation or cetuximab-irradiation.

Stuart E Samuels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.